Royal Bafokeng Holdings’ executive Katlego Kobue resigns from Dis-Chem board after 5 years

Feyisayo Ajayi
Feyisayo Ajayi
Katlego Kobue

South African investment professional and senior investment manager of Royal Bafokeng Holdings (RBH), Katlego Kobue has resigned from the board of Dis-Chem Pharmacies, ending a five-year tenure during which he represented RBH, one of the pharmacy retailer’s shareholders.

Dis-Chem, one of South Africa’s largest pharmacy groups, announced in a JSE regulatory filing on November 16, 2026, that Katlego Kobue stepped down as a non-executive director with effect from November 12.

Kobue joined Dis-Chem through Royal Bafokeng Holdings investment

The company said its board appreciated his contribution and dedicated service during his tenure, wishing him success in his future endeavours. The announcement was issued by company secretary Nikki Lumley.

Katlego Kobue, based in Gauteng, joined the Johannesburg-listed retailer’s board in November 2021, with his appointment formally announced on November 24 that year, following an effective start date of November 22. His appointment in 2021 followed RBH’s acquisition of a 6.62% stake in Dis-Chem as part of a broad-based black economic empowerment transaction. He joined as a non-independent non-executive director, representing the investment holding company.

During his time on the board, Katlego Kobue also served on Dis-Chem’s Social and Ethics, Nominations, and Remuneration committees, giving him oversight responsibilities across governance, executive compensation and corporate conduct.

His departure ends RBH’s board representation at Dis-Chem through Kobue, although the investment firm’s shareholding remains unchanged by the announcement. Dis-Chem’s 2026 annual report, however, shows that RBH held a 3.48% stake in the retailer, equivalent to 29.94 million shares.

Royal Bafokeng Holdings investment career

Kobue is a senior investment manager at Royal Bafokeng Holdings, where he has worked since 2011. He progressed through several positions at the investment company, including intern, junior investment manager and investment manager, before becoming senior investment manager in January 2020.

His responsibilities include evaluating investment opportunities, conducting due diligence, managing investment portfolios and representing RBH on the boards of companies in which it holds interests.

His experience in investment analysis and corporate governance formed the professional background to his appointment at Dis-Chem, where he served alongside other directors during a period of continued expansion in the South African pharmaceutical retail market.

Kobue retains other corporate board responsibilities

Beyond his role at Dis-Chem, Kobue serves as a non-executive director of YeboYethu Limited, maintaining an active presence in South African corporate governance.

He holds a Bachelor of Commerce degree in Corporate Finance and Investments from the University of the Witwatersrand, as well as a Certificate in Portfolio Management.

Dis-Chem’s announcement did not disclose the reason for his resignation or identify a successor. The company said its board wished him well in his future endeavours.

Katlego Kobue
Katlego Kobue
Share This Article